U.S. health agencies to study heart risks of ADHD drugs

09/17/2007 | Reuters

The FDA is poised to work with the Agency for Healthcare Research and Quality on a study of the potential heart risks posed by drugs used in treating attention deficit hyperactivity disorder, health officials announced Monday. The two-year study will look into medical records of approximately 500,000 children and adults who have taken ADHD drugs, such as Ritalin and Adderall, which can increase heart rate and blood pressure in patients.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Program Coordinator/Lecturer for the Regulatory Science program
Johns Hopkins University
Washington, DC
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA